These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 26315089)

  • 21. Development of a luciferase-based system for the detection of ZnT8 autoantibodies.
    Ustinova J; Zusinaite E; Utt M; Metsküla K; Reimand K; Huchaiah V; Merits A; Uibo R
    J Immunol Methods; 2014 Mar; 405():67-73. PubMed ID: 24462542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Update on the ZNT8 epitope and its role in the pathogenesis of type 1 diabetes.
    Yang L; Zhang X; Liu Q; Wen Y; Wang Q
    Minerva Endocrinol (Torino); 2023 Dec; 48(4):447-458. PubMed ID: 38099391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoantibodies to insulin, insulinoma-associated antigen-2, and zinc transporter 8 improve the prediction of early insulin requirement in adult-onset autoimmune diabetes.
    Kawasaki E; Nakamura K; Kuriya G; Satoh T; Kuwahara H; Kobayashi M; Abiru N; Yamasaki H; Eguchi K
    J Clin Endocrinol Metab; 2010 Feb; 95(2):707-13. PubMed ID: 20061424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel enzyme-linked immunosorbent assay for bivalent ZnT8 autoantibodies.
    Kawasaki E; Tanaka M; Miwa M; Abiru N; Kawakami A
    Acta Diabetol; 2014; 51(3):429-34. PubMed ID: 24292540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel triple mix radiobinding assay for the three ZnT8 (ZnT8-RWQ) autoantibody variants in children with newly diagnosed diabetes.
    Vaziri-Sani F; Delli AJ; Elding-Larsson H; Lindblad B; Carlsson A; Forsander G; Ivarsson SA; Ludvigsson J; Marcus C; Lernmark Å
    J Immunol Methods; 2011 Aug; 371(1-2):25-37. PubMed ID: 21708156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of HLA class I-restricted T-cell epitopes of islet autoantigen combined with binding and dissociation assays.
    Wu X; Xu X; Gu R; Wang Z; Chen H; Xu K; Zhang M; Hutton J; Yang T
    Autoimmunity; 2012 Mar; 45(2):176-85. PubMed ID: 22260783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antigenicity and epitope specificity of ZnT8 autoantibodies in type 1 diabetes.
    Skärstrand H; Lernmark A; Vaziri-Sani F
    Scand J Immunol; 2013 Jan; 77(1):21-9. PubMed ID: 23126564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Zinc transporter type 8 autoantibodies (ZnT8A): prevalence and phenotypic associations in latent autoimmune diabetes patients and patients with adult onset type 1 diabetes.
    Andersen MK; Härkönen T; Forsblom C; Groop PH; Knip M; Tuomi T
    Autoimmunity; 2013 Jun; 46(4):251-8. PubMed ID: 23194113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Zinc transporter 8 autoantibodies and their association with SLC30A8 and HLA-DQ genes differ between immigrant and Swedish patients with newly diagnosed type 1 diabetes in the Better Diabetes Diagnosis study.
    Delli AJ; Vaziri-Sani F; Lindblad B; Elding-Larsson H; Carlsson A; Forsander G; Ivarsson SA; Ludvigsson J; Kockum I; Marcus C; Samuelsson U; Örtqvist E; Groop L; Bondinas GP; Papadopoulos GK; Lernmark Å;
    Diabetes; 2012 Oct; 61(10):2556-64. PubMed ID: 22787139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Zinc transporter 8 autoantibodies assessment in daily practice.
    Hussein H; Ibrahim F; Sobngwi E; Gautier JF; Boudou P
    Clin Biochem; 2017 Jan; 50(1-2):94-96. PubMed ID: 27363941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Zinc transporter 8 (ZnT8) autoantibody epitope specificity and affinity examined with recombinant ZnT8 variant proteins in specific ZnT8R and ZnT8W autoantibody-positive type 1 diabetes patients.
    Skärstrand H; Krupinska E; Haataja TJ; Vaziri-Sani F; Lagerstedt JO; Lernmark Å
    Clin Exp Immunol; 2015 Feb; 179(2):220-9. PubMed ID: 25178386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between anti-ZnT8 autoantibody specificities and SLC30A8 Arg325Trp variant in Japanese patients with type 1 diabetes.
    Kawasaki E; Uga M; Nakamura K; Kuriya G; Satoh T; Fujishima K; Ozaki M; Abiru N; Yamasaki H; Wenzlau JM; Davidson HW; Hutton JC; Eguchi K
    Diabetologia; 2008 Dec; 51(12):2299-302. PubMed ID: 18850084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of autoantibodies to zinc transporter 8 in prediction of type 1 diabetes in relatives: lessons from the European Nicotinamide Diabetes Intervention Trial (ENDIT) cohort.
    Long AE; Gooneratne AT; Rokni S; Williams AJ; Bingley PJ
    J Clin Endocrinol Metab; 2012 Feb; 97(2):632-7. PubMed ID: 22162482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoantibodies against zinc transporter 8 are related to age, metabolic state and HLA DR genotype in children with newly diagnosed type 1 diabetes.
    Salonen KM; Ryhänen S; Härkönen T; Ilonen J; Knip M;
    Diabetes Metab Res Rev; 2013 Nov; 29(8):646-54. PubMed ID: 23861236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoantibodies against zinc transporter 8 further stratify the autoantibody-defined risk for type 1 diabetes in a general population of schoolchildren and have distinctive isoform binding patterns in different forms of autoimmune diabetes: results from the Karlsburg Type 1 Diabetes Risk Study.
    Baumann K; Kesselring K; Lampasona V; Walschus U; Kerner W; Wassmuth R; Schlosser M
    Diabet Med; 2021 Feb; 38(2):e14389. PubMed ID: 32799407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prokaryotic Expression of Bioactive Zinc Transporter 8 Antigens and Detection of Diabetes Specific Autoantibodies in a Single Dot Immunogold Filtration Assay.
    Cheng L; Li T; Zhang D; Chen B
    Clin Lab; 2015; 61(10):1445-52. PubMed ID: 26642706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diabetes antibody standardization program: first proficiency evaluation of assays for autoantibodies to zinc transporter 8.
    Lampasona V; Schlosser M; Mueller PW; Williams AJ; Wenzlau JM; Hutton JC; Achenbach P
    Clin Chem; 2011 Dec; 57(12):1693-702. PubMed ID: 21980171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoantibodies against zinc transporter 8 are related to age and metabolic state in patients with newly diagnosed autoimmune diabetes.
    Niechciał E; Rogowicz-Frontczak A; Piłaciński S; Fichna M; Skowrońska B; Fichna P; Zozulińska-Ziółkiewicz D
    Acta Diabetol; 2018 Mar; 55(3):287-294. PubMed ID: 29327148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antigen-specific immunotherapies in type 1 diabetes.
    Zhang X; Dong Y; Liu D; Yang L; Xu J; Wang Q
    J Trace Elem Med Biol; 2022 Sep; 73():127040. PubMed ID: 35868165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Zinc transporter 8 antibodies complement GAD and IA-2 antibodies in the identification and characterization of adult-onset autoimmune diabetes: Non Insulin Requiring Autoimmune Diabetes (NIRAD) 4.
    Lampasona V; Petrone A; Tiberti C; Capizzi M; Spoletini M; di Pietro S; Songini M; Bonicchio S; Giorgino F; Bonifacio E; Bosi E; Buzzetti R;
    Diabetes Care; 2010 Jan; 33(1):104-8. PubMed ID: 19808923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.